시간 외 거래: 5.52 0.13 +2.41%

Inmune Bio Inc (INMB)

Inmune Bio Inc 주식(INMB)의 최신 뉴스

Inmune Bio Inc (INMB)

Inmune Bio Inc 주식(INMB)의 최신 뉴스

Inmune Bio CFO buys $52,868 in company stock By Investing.com - Investing.com Canada

Analytical Overview: INmune Bio Inc (INMB)’s Ratios Tell a Financial Story - The Dwinnex

INmune Bio Inc [INMB] Investment Guide: What You Need to Know - Knox Daily

INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease - The Manila Times

INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease - Post Register

INmune Bio Inc. Completes Enrollment for Phase 2 Trial in Early Alzheimer's Disease - StockTitan

INmune Bio: NK Cell Therapy INKmune For mCRPC Is Another Shot On Goal (NASDAQ:INMB) - Seeking Alpha

CVI Holdings LLC Purchases New Position in INmune Bio, Inc. (NASDAQ:INMB) - Defense World

CVI Holdings LLC Purchases New Position in INmune Bio, Inc. (NASDAQ:INMB) - MarketBeat

Raymond James Initiates Coverage of INmune Bio (INMB) with Outperform Recommendation - MSN

Achieve, INmune, Lenz stocks win bullish view from RayJay - Seeking Alpha

INmune Bio (NASDAQ:INMB) Coverage Initiated by Analysts at Raymond James - Defense World

INmune Bio (NASDAQ:INMB) Coverage Initiated by Analysts at Raymond James - MarketBeat

INmune Bio reports progress in prostate cancer trial By Investing.com - Investing.com Canada

INmune Bio reports progress in prostate cancer trial - Investing.com

INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort - The Manila Times

INKmune™ Demonstrates Excellent Safety and Increased NK-Cell Activity in First Dosing Cohort - EIN News

UCB rapidly bolsters blockbuster potential for Bimzelx with 3 new FDA approvals - FiercePharma

What is the investor’s view on Immunic Inc (IMUX)? - US Post News

You might want to take a look at Inuvo Inc (INUV) now - SETE News

Imunon Inc (IMNN) may enjoy gains as insiders got busy in the recent days - Knox Daily

Gaining Ground: Universe Pharmaceuticals INC (UPC) Closes Lower at 0.29, Down -13.83 - The Dwinnex

Innate Pharma Advances Novel Cancer Treatment - TipRanks

Century Therapeutics, Inc. (NASDAQ:IPSC) Stake Cut by Federated Hermes Inc. - MarketBeat

Innate Pharma: green light from the FDA for a study - Marketscreener.com

Itau Unibanco Holding S.A. Trims Stock Holdings in Micron Technology, Inc. (NASDAQ:MU) - Defense World

Integrated BioPharma (OTCMKTS:INBP) Posts Quarterly Earnings Results - Defense World

ImmunityBio: Anktiva Launch, Good Data, Low Cash, High Debt (NASDAQ:IBRX) - Seeking Alpha

Mutual of America Capital Management LLC Sells 5,171 Shares of CubeSmart (NYSE:CUBE) - Defense World

INmune Bio stock hits 52-week low at $5.17 amid market challenges By Investing.com - Investing.com South Africa

INmune Bio stock hits 52-week low at $5.17 amid market challenges - Investing.com

How To Trade (INMB) - Stock Traders Daily

Just the Facts: Imugene receives Orphan Drug Designation for VAXINIA from FDA - Proactive Investors Australia

You might want to take a look at Imunon Inc (IMNN) now - SETE News

INmune Bio stock remains a Buy with positive data correlation in Alzheimer’s study, says Scotiabank - Investing.com Australia

Raymond Tesi Buys Handful Of Shares In INmune Bio - Simply Wall St

BTIG maintains Buy rating on INmune Bio shares with steady price target - Investing.com Canada

INmune Bio, Inc. (NASDAQ:INMB) Sees Large Increase in Short Interest - MarketBeat

INmune Bio, Inc. (NASDAQ:INMB) Sees Large Increase in Short Interest - Defense World

BTIG maintains Buy rating on INmune Bio shares with steady price target - Investing.com

INmune Bio stock remains a Buy with positive data correlation in Alzheimer’s study, says Scotiabank - Investing.com

Its Stock Has Paid Off Big Time For INmune Bio Inc - SETE News

Market Watch: Immuneering Corp (IMRX)’s Noteworthy Drop, Closing at 2.78 - The Dwinnex

INmune Bio reports strong data from Alzheimer's trial - Investing.com

INmune Bio reports strong data from Alzheimer's trial By Investing.com - Investing.com Canada

INmune Bio reports strong data from Alzheimer's trial - Investing.com India

INmune Bio reports strong data from Alzheimer's trial By Investing.com - Investing.com South Africa

INmune Bio announces results of additional interim analysis of Phase 2 trial - TipRanks

INmune Bio reports strong data from Alzheimer's trial By Investing.com - Investing.com UK

INmune Bio Announces Results of Additional Blinded Interim Analysis of Phase 2 Alzheimer's Disease Trial Demonstrating Correlation between EMACC and CDR-SB Endpoints - StockTitan

How to interpret INmune Bio Inc (INMB)’s stock chart patterns - US Post News

INmune Bio, Inc. (NASDAQ:INMB) CEO Raymond Joseph Tesi Purchases 15,380 Shares - Defense World

Inmune Bio CFO buys $49k in company stock By Investing.com - Investing.com Australia

Inmune Bio CFO buys $49k in company stock By Investing.com - Investing.com Canada

Inmune Bio CEO acquires $98k in company stock By Investing.com - Investing.com Australia

Inmune Bio CEO acquires $98k in company stock By Investing.com - Investing.com Canada

Inmune Bio CEO acquires $98k in company stock - Investing.com

Inmune Bio CFO acquires $49k in company stock - Investing.com

Inmune Bio CFO buys $49k in company stock By Investing.com - Investing.com UK

Inmune Bio CFO acquires $49k in company stock By Investing.com - Investing.com UK

Understanding the Risks of Investing in INmune Bio Inc (INMB) - Knox Daily

INmune Bio Inc (INMB) Stock: 52-Week Performance Showcases Highs, Lows, and Trading Volume - The InvestChronicle

SEC Form 424B5 filed by INmune Bio Inc. - Quantisnow

Closing Figures Unveiled: INmune Bio Inc (INMB) Drop -14.55, Closes at 5.46 - The Dwinnex

Inmune Bio CFO acquires $49k in company stock By Investing.com - Investing.com Canada

INmune Bio stock hits 52-week low at $5.58 amid market challenges - Investing.com

INmune Bio stock hits 52-week low at $5.58 amid market challenges - Investing.com India

INmune Bio secures $13 million in stock and warrant sale - Investing.com

INmune Bio Shares Fall After $13M Direct Offering Prices - MarketWatch

INmune Bio stock hits 52-week low at $5.58 amid market challenges - Investing.com UK

INmune Bio stock dips on $13M securities offering - MSN

INmune Bio secures $13 million in stock and warrant sale - Investing.com India

INmune Bio secures $13 million in stock and warrant sale By Investing.com - Investing.com UK

INmune Bio Announces $13.0 Million Registered Direct Offering - EIN News

INmune Bio, Inc.'s (NASDAQ:INMB) top owners are individual investors with 44% stake, while 23% is held by institutions - Yahoo Finance

Keeping an Eye on INmune Bio Inc (INMB) After Insider Trading Activity - Knox Daily

AerSale Corp [ASLE] insider makes an insider purchase of 1,135 shares worth 5844.0. - Knox Daily

INMB과 유사한 종목